Better Edge : A Northwestern Medicine podcast for physicians
Better Edge : A Northwestern Medicine podcast for physicians
Von Hippel-Lindau Disease: Clinical Update and New Drug Therapy
Loading
/
  • LISTEN ON:
  • Listen on Spotify
  • Listen on iHeart
  • Listen on Apple Podcasts
  • Listen on Google Podcasts
  • Listen on TuneIn
  • Listen on Stitcher
Placeholder Ad
Placeholder Ad
Placeholder Ad
Placeholder Ad

Von Hippel-Lindau Disease: Clinical Update and New Drug Therapy

von-hippel-lindau-disease-clinical-update-and-new-drug-therapy

Von Hippel-Lindau (VHL) disease is a rare hereditary cancer syndrome caused by mutations in the VHL gene. These mutations predispose patients to the development of cysts and tumors in several systems and organs, including the central nervous system, retina, kidneys, pancreas, adrenal glands and reproductive organs. VHL is a complex disease that requires specialized advanced treatment from a multidisciplinary team of specialists.

In this Better Edge podcast episode, the following experts from the Northwestern Medicine Von Hippel-Lindau Disease Program discuss VHL and the clinical management for this patient population: Rimas V. Lukas, MD, Associate Professor of Neuro-Oncology; Niraj K. Shenoy, MD, PhD, MS, Associate Professor of Hematology/Oncology and of Pathology; and Brittany M. Szymaniak, PhD, CGC, Instructor of Urology. They share a recent Northwestern Medicine study published in Neuro-Oncology that examined belzutifan, the first approved HIF-2? inhibitor, in VHL-associated tumors.

Inside Northwestern Medicine’s Gay and Bisexual Men’s Urology Program

Von Hippel-Lindau (VHL) disease is a rare hereditary cancer syndrome caused by mutations in the VHL gene. These mutations predispose ...

Listen

Pericardial Disease: Its Prevalence and the Role of Multidisciplinary Care

Von Hippel-Lindau (VHL) disease is a rare hereditary cancer syndrome caused by mutations in the VHL gene. These mutations predispose ...

Listen

Northwestern Medicine Geriatrics Home Care Program

Von Hippel-Lindau (VHL) disease is a rare hereditary cancer syndrome caused by mutations in the VHL gene. These mutations predispose ...

Listen

Continuity Matters: Transitioning Pediatric Patients to Adult Specialists

Von Hippel-Lindau (VHL) disease is a rare hereditary cancer syndrome caused by mutations in the VHL gene. These mutations predispose ...

Listen

The Connection Between Diabetes and Heart Disease

Von Hippel-Lindau (VHL) disease is a rare hereditary cancer syndrome caused by mutations in the VHL gene. These mutations predispose ...

Listen

Socioeconomic Status and Readmission After Acute Type A Aortic Dissection Repair

Von Hippel-Lindau (VHL) disease is a rare hereditary cancer syndrome caused by mutations in the VHL gene. These mutations predispose ...

Listen

Highlights from AAN 2024

Von Hippel-Lindau (VHL) disease is a rare hereditary cancer syndrome caused by mutations in the VHL gene. These mutations predispose ...

Listen

From Brain to Liver: Advances in Wilson Disease Management

Von Hippel-Lindau (VHL) disease is a rare hereditary cancer syndrome caused by mutations in the VHL gene. These mutations predispose ...

Listen

First Seizure Clinic

Von Hippel-Lindau (VHL) disease is a rare hereditary cancer syndrome caused by mutations in the VHL gene. These mutations predispose ...

Listen

Seizure Solutions: Inside the Northwestern Medicine First Seizure Clinic

Von Hippel-Lindau (VHL) disease is a rare hereditary cancer syndrome caused by mutations in the VHL gene. These mutations predispose ...

Listen